A multinational review: Oesophageal cancer in low to middle‑income countries (Review)
- Authors:
- Rodney Hull
- Mzwandile Mbele
- Tshepiso Makhafola
- Chindo Hicks
- Shao Ming Wang
- Rui Manuel Reis
- Ravi Mehrotra
- Zilungile Mkhize‑Kwitshana
- Showket Hussain
- Gibson Kibiki
- David O. Bates
- Zodwa Dlamini
-
Affiliations: South African‑Medical Research Council/University of Pretoria Precision, Prevention and Novel Drug Targets for HIV‑Associated Cancers Extramural Unit, Cancer Research Institute, University of Pretoria, Faculty of Health Sciences, Pretoria, Gauteng 0028, South Africa, Louisiana State University, School of Medicine, Department of Genetics, Bioinformatics and Genomics Centre, LA 70112, USA, National Cancer Centre, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China, Molecular Oncology Research Centre, Barretos Cancer Hospital, CEP 14784 400, Sao Paulo, Brazil, Indian Council of Medical Research, 110029 New Delhi, India, School of Medicine, University of Kwazulu‑Natal, Durban, KwaZulu-Natal 4013, South Africa, East African Health Research Commission, East African Community, Quartier Kigobe, 1096 Arusha, United Republic of Tanzania, University of Nottingham, Queens Medical Centre, Cancer Biology, NG7 2UH Nottingham, UK - Published online on: July 24, 2020 https://doi.org/10.3892/ol.2020.11902
- Article Number: 42
-
Copyright: © Hull et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
|
Henry MA, Lerco MM, Ribeiro PW and Rodrigues MA: Epidemiological features of esophageal cancer. Squamous cell carcinoma versus adenocarcinoma. Acta Cir Bras. 29:389–393. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Cook MB, Chow WH and Devesa SS: Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977–2005. Br J Cancer. 101:855–859. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, Negri E and La Vecchia C: Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer. 122:1118–1129. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Torre LA, Siegel RL, Ward EM and Jemal A: Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Das M, Saikia BJ, Sharma SK, Sekhon GS, Mahanta J and Phukan RK: p16 hypermethylation: A biomarker for increased esophageal cancer susceptibility in high incidence region of North East India. Tumour Biol. 36:1627–1642. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hongo M, Nagasaki Y and Shoji T: Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol. 24:729–735. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Launay L, Dejardin O, Pornet C, Morlais F, Guittet L, Launoy G and Bouvier V: Influence of socioeconomic environment on survival in patients diagnosed with esophageal cancer: A population-based study. Dis Esophagus. 25:723–730. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lambert R and Hainaut P: Esophageal cancer: Cases and causes (part I). Endoscopy. 39:550–555. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Napier KJ, Scheerer M and Misra S: Esophageal cancer: A review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Herszényi L and Tulassay Z: Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci. 14:249–258. 2010.PubMed/NCBI | |
|
Zhang L, Ma W and Li Y: Huge primary malignant melanoma of the esophagus: A case report and literature review. Thorac Cancer. 4:479–483. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta V, Coburn N, Kidane B, Hess KR, Compton C, Ringash J, Darling G and Mahar AL: Survival prediction tools for esophageal and gastroesophageal junction cancer: A systematic review. J Thorac Cardiovasc Surg. 156:847–856. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y: Epidemiology of esophageal cancer. World J Gastroenterol. 19:5598–5606. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Daly JM, Fry WA, Little AG, Winchester DP, McKee RF, Stewart AK and Fremgen AM: Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg. 190:562–573. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
World Health Organisation: Global status report on alcohol and health, 2014. February 15–2020 | |
|
World Health Organisation: Prevalence of tobacco smoking, 2015. November 18–2018 | |
|
Akbari MR, Malekzadeh R, Shakeri R, Nasrollahzadeh D, Foumani M, Sun Y, Pourshams A, Sadjadi A, Jafari E, Sotoudeh M, et al: Candidate gene association study of esophageal squamous cell carcinoma in a high-risk region in Iran. Cancer Res. 69:7994–8000. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart BW and Kleihues P: World Cancer Report. IARC Press; Lyon: 2003 | |
|
Brown LM, Hoover RN, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, Liff JM, Silverman DT, Hayes RB and Pottern LM: Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst. 86:1340–1345. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Muwonge R, Ramadas K, Sankila R, Thara S, Thomas G, Vinoda J and Sankaranarayanan R: Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: A nested case-control design using incident cancer cases. Oral Oncol. 44:446–454. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Blot W, McLaughlin J and Fraumeni J Jr: Esophageal cancer. Oxford University Press Oxford; 2006, View Article : Google Scholar | |
|
Blot W and Tarone R: Esophageal cancer. Cancer epidemiology and prevention. Thun M, Linet M, Cerhan L, Haiman C and Schottenfeld D: Oxford University Press; Oxford: pp. 579–592. 2006 | |
|
Blot W, McLaughlin J and Fraumeni JJ Jr: Esophageal Cancer. Cancer Epidemiology and Prevention. Thun M, Linet M, Cerhan J, Haiman C and Schottenfeld D: 4th. Oxford University Press; Oxford: pp. 697–707. 2006, View Article : Google Scholar | |
|
Nieman DR and Peters JH: Treatment strategies for esophageal cancer. Gastroenterol Clin North Am. 42:187–197. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Wang KK and Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology, : Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol. 103:788–797. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Khan NA, Teli MA, Mohib-Ul Haq M, Bhat GM, Lone MM and Afroz F: A survey of risk factors in carcinoma esophagus in the valley of Kashmir, Northern India. J Cancer Res Ther. 7:15–18. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Islami F, Kamangar F, Nasrollahzadeh D, Aghcheli K, Sotoudeh M, Abedi-Ardekani B, Merat S, Nasseri-Moghaddam S, Semnani S, Sepehr A, et al: Socio-economic status and oesophageal cancer: Results from a population-based case-control study in a high-risk area. Int J Epidemiol. 38:978–988. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Siddiqi M, Kumar R, Kaul D, Spiegelhalder B and Preussmann R: Salivary nitrate and nitrite concentrations from a sample population of children and adults in high risk area for esophageal and gastric cancers in Kashmir, India. Cancer Lett. 64:133–136. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Gupta B and Kumar N: Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev. 26:107–118. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Hussain S, M Y, Thakur N, Salam I, Singh N, Mir MM, Bhat MA, Siddiqi MA, Das BC and Bharadwaj M: Association of cyclin D1 gene polymorphisms with risk of esophageal squamous cell carcinoma in Kashmir Valley: A high risk area. Mol Carcinog. 50:487–498. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Enzinger PC and Mayer RJ: Esophageal cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Arnold M, Soerjomataram I, Ferlay J and Forman D: Global incidence of oesophageal cancer by histological subtype in 2012. Gut. 64:381–387. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Eslick GD: Epidemiology of esophageal cancer. Gastroenterol Clin North Am. 38:17–25. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Thuler FP, Forones NM and Ferrari AP: Advanced esophageal cancer: Still a delayed diagnosis. Arq Gastroenterol. 43:206–211. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Barrios E, Sierra MS, Musetti C and Forman D: The burden of oesophageal cancer in Central and South America. Cancer Epidemiol. 44 (Suppl 1):S53–S61. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pennathur A, Gibson MK, Jobe BA and Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Segal I, Reinach SG and de Beer M: Factors associated with oesophageal cancer in Soweto, South Africa. Br J Cancer. 58:681–686. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Higginson J and Oettle AG: Cancer incidence in the Bantu and ‘Cape Colored’ races of South Africa: Report of a cancer survey in the Transvaal (1953–55). J Natl Cancer Inst. 24:589–671. 1960. View Article : Google Scholar : PubMed/NCBIPubMed/NCBI | |
|
Oettl AJSAMJ: An epidemic of oesophageal carcinoma in Africa. 37:4351963. | |
|
Rose EF: Esophageal cancer in the Transkei: 1955–69. J Natl Cancer Inst. 51:7–16. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M and Parkin DM: Cancer burden in Africa and opportunities for prevention. Cancer. 118:4372–4384. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Blot WJ: Esophageal cancer trends and risk factors. Semin Oncol. 21:403–410. 1994.PubMed/NCBI | |
|
Sammon AM: Carcinogens and endemic squamous cancer of the oesophagus in Transkei, South Africa. Environmental initiation is the dominant factor; tobacco or other carcinogens of low potency or concentration are sufficient for carcinogenesis in the predisposed mucosa. Med Hypotheses. 69:125–131. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Makaula AN, Marasas WF, Venter FS, Badenhorst CJ, Bradshaw D and Swanevelder S: Oesophageal and other cancer patterns in four selected districts of the Transkei, Southern Africa: 1985–1990. Afr J Health Sci. 3:11–15. 1996.PubMed/NCBI | |
|
Bizos D, Morgan H, Motha N, Makda M, Domingo A, Tiedt S, Wing J, Munanga M, Tembo J, Hale M and Bizos D: Comparison of the incidence of oesophageal cancer in two 6-year periods from selected hospitals in and around Gauteng Province, South Africa. South Afr J Surg. 53:55–58. 2015. View Article : Google Scholar | |
|
Lagergren J, Bergström R, Lindgren A and Nyrén O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 340:825–831. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy P, Zuma K, Shisana O, Jonas K and Sewpaul R: Prevalence of tobacco use among adults in South Africa: Results from the first South African National Health and Nutrition Examination Survey. S Afr Med J. 105:648–655. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Sewram V, Sitas F, O'Connell D and Myers J: Tobacco and alcohol as risk factors for oesophageal cancer in a high incidence area in South Africa. Cancer Epidemiol. 41:113–121. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Dlamini Z and Bhoola K: Esophageal cancer in African blacks of Kwazulu Natal, South Africa: An epidemiological brief. Ethn Dis. 15:786–789. 2005.PubMed/NCBI | |
|
Schandl L, Malfertheiner P and Ebert MP: Prevention of gastric cancer by Helicobacter pylori eradication? Dig Dis. 20:18–22. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, Kikuchi S, Inoue M, Tanaka H and He Y: Esophageal cancer in high-risk areas of China: Research progress and challenges. Ann Epidemiol. 27:215–221. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Long N, Moore MA, Chen W, Gao CM, Lai MS, Mizoue T, Oyunchimeg D, Park S, Shin HR, Tajima K, et al: Cancer epidemiology and control in north-East Asia-past, present and future. Asian Pac J Cancer Prev. 11 (Suppl 2):S107–S148. 2010. | |
|
Wang AH, Sun CS, Li LS, Huang JY and Chen QS: Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an. World J Gastroenterol. 8:49–53. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sewram V, Sitas F, O'Connell D and Myers J: Diet and esophageal cancer risk in the Eastern Cape Province of South Africa. Nutr Cancer. 66:791–799. 2014. | |
|
Jaskiewicz K: Oesophageal carcinoma: Cytopathology and nutritional aspects in aetiology. Anticancer Res. 9:1847–1852. 1989.PubMed/NCBI | |
|
Pink RC, Bailey TA, Iputo JE, Sammon AM, Woodman AC and Carter DR: Molecular basis for maize as a risk factor for esophageal cancer in a South African population via a prostaglandin E2 positive feedback mechanism. Nutr Cancer. 63:714–721. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gabel JV, Chamberlain RM, Ngoma T, Mwaiselage J, Schmid KK, Kahesa C and Soliman AS: Clinical and epidemiologic variations of esophageal cancer in Tanzania. World J Gastrointest Oncol. 8:314–320. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
McHembe MD, Rambau PF, Chalya PL, Jaka H, Koy M and Mahalu W: Endoscopic and clinicopathological patterns of esophageal cancer in Tanzania: Experiences from two tertiary health institutions. World J Surg Oncol. 11:2572013. View Article : Google Scholar : PubMed/NCBI | |
|
Munishi MO, Hanisch R, Mapunda O, Ndyetabura T, Ndaro A, Schüz J, Kibiki G and McCormack V: Africa's oesophageal cancer corridor: Do hot beverages contribute? Cancer Causes Control. 26:1477–1486. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Patel K, Wakhisi J, Mining S, Mwangi A and Patel R: Esophageal cancer, the topmost cancer at MTRH in the Rift Valley, Kenya, and its potential risk factors. ISRN Oncol. 2013:5032492013.PubMed/NCBI | |
|
Khuroo MS, Zargar SA, Mahajan R and Banday MA: High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 33:11–15. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, et al: International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N and Das BC: p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett. 218:69–79. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Salam I, Hussain S, Mir MM, Dar NA, Abdullah S, Siddiqi MA, Lone RA, Zargar SA, Sharma S, Hedau S, et al: Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: A high-risk area. Mol Cell Biochem. 332:51–58. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chen M, Huang J, Zhu Z, Zhang J and Li K: Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. BMC Cancer. 13:5392013. View Article : Google Scholar : PubMed/NCBI | |
|
Guo W, Blot WJ, Li JY, Taylor PR, Liu BQ, Wang W, Wu YP, Zheng W, Dawsey SM, Li B, et al: A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol. 23:444–450. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Parkin DM, Stjernsward J and Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ. 62:163–182. 1984.PubMed/NCBI | |
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Pohl H and Welch HG: The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 97:142–146. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W and Blot WJ: Prevention of esophageal cancer: The nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 54 (Suppl 7):2029S–2031S. 1994.PubMed/NCBI | |
|
Yang CS: Research on esophageal cancer in China: A review. Cancer Res. 40:2633–2644. 1980.PubMed/NCBI | |
|
Wu M, Liu AM, Kampman E, Zhang ZF, Van't Veer P, Wu DL, Wang PH, Yang J, Qin Y, Mu LN, et al: Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: A population-based case-control study. Int J Cancer. 124:1907–1913. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kamangar F, Diaw L, Wei WQ, Abnet CC, Wang GQ, Roth MJ, Liu B, Lu N, Giffen C, Qiao YL and Dawsey SM: Serum pepsinogens and risk of esophageal squamous dysplasia. Int J Cancer. 124:456–460. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Hsia J and Yang G: Prevalence of smoking in China in 2010. N Engl J Med. 364:2469–2470. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Salaspuro M: Acetaldehyde and gastric cancer. J Dig Dis. 12:51–59. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kollarova H, Machova L, Horakova D, Janoutova G and Janout V: Epidemiology of esophageal cancer-an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 151:17–20. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ribeiro Pinto LF, Teixeira Rossini AM, Albano RM, Felzenszwalb I, de Moura Gallo CV, Nunes RA and Andreollo NA: Mechanisms of esophageal cancer development in Brazilians. Mutat Res. 544:365–373. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Mota OM, Curado MP, Oliveira JC, Martins E and Cardoso DM: Risk factors for esophageal cancer in a low-incidence area of Brazil. Sao Paulo Med J. 131:27–34. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, He Y, Xu J, Xu L, Du J, Zhu C, Gu H, Ma H, Hu Z, Jin G, et al: Genetic variants at 4q21, 4q23 and 12q24 are associated with esophageal squamous cell carcinoma risk in a Chinese population. Hum Genet. 132:649–656. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Vioque J, Barber X, Bolumar F, Porta M, Santibáñez M, de la Hera MG and Moreno-Osset E; PANESOES Study Group, : Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. BMC Cancer. 8:2212008. View Article : Google Scholar : PubMed/NCBI | |
|
Pun C, Aryal G, Basyal R, Shrestha S, Pathak T, Bastola S, Neupane S, Shrestha BM, Thakur BK and Lee MC: Histological pattern of esophageal cancer at BP Koirala memorial cancer hospital in Nepal: A three year retrospective study. J Pathol Nepal. 2:277–281. 2012. View Article : Google Scholar | |
|
Ali A, Ersumo T and Johnson O: Oesophageal carcinoma in Tikur Anbessa Hospital, Addis Ababa. East Afr Med J. 75:590–593. 1998.PubMed/NCBI | |
|
Schlansky B, Dimarino AJ Jr, Loren D, Infantolino A, Kowalski T and Cohen S: A survey of oesophageal cancer: Pathology, stage and clinical presentation. Aliment Pharmacol Ther. 23:587–593. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Cherian JV, Sivaraman R, Muthusamy AK and Jayanthi V: Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center. J Gastrointestin Liver Dis. 16:245–249. 2007.PubMed/NCBI | |
|
Fan YJ, Song X, Li JL, Li XM, Liu B, Wang R, Fan ZM and Wang LD: Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: A histopathological comparison during 24-year period. World J Surg. 32:1980–1988. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gomez SL, Le GM, Clarke CA, Glaser SL, France AM and West DW: Cancer incidence patterns in Koreans in the US and in Kangwha, South Korea. Cancer Causes Control. 14:167–174. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Stellman SD and Wang QS: Cancer mortality in Chinese immigrants to New York City. Comparison with Chinese in Tianjin and with United States-born whites. Cancer. 73:1270–1275. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Testa U, Castelli G and Pelosi E: Esophageal Cancer: Genomic and molecular characterization, stem cell compartment and clonal evolution. Medicines (Basel). 4:E672017. View Article : Google Scholar : PubMed/NCBI | |
|
Tomczak K, Czerwinska P and Wiznerowicz M: The Cancer Genome Atlas (TCGA): An immeasurable source of knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI | |
|
Agrawal N, Jiao Y, Bettegowda C, Hutfless SM, Wang Y, David S, Cheng Y, Twaddell WS, Latt NL, Shin EJ, et al: Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2:899–905. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Secrier M, Li X, de Silva N, Eldridge MD, Contino G, Bornschein J, MacRae S, Grehan N, O'Donovan M, Miremadi A, et al: Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nat Genet. 48:1131–1141. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, et al: A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 45:1487–1493. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Sawada G, Niida A, Uchi R, Hirata H, Shimamura T, Suzuki Y, Shiraishi Y, Chiba K, Imoto S, Takahashi Y, et al: Genomic landscape of esophageal squamous cell carcinoma in a Japanese population. Gastroenterology. 150:1171–1182. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chang J, Tan W, Ling Z, Xi R, Shao M, Chen M, Luo Y, Zhao Y, Liu Y, Huang X, et al: Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat Commun. 8:152902017. View Article : Google Scholar : PubMed/NCBI | |
|
Manolio TA: Genomewide association studies and assessment of the risk of disease. N Engl J Med. 363:166–176. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z and Raftery D: Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One. 7:e301812012. View Article : Google Scholar : PubMed/NCBI | |
|
Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI and Mathew CG: Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis. 32:1855–1861. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lao-Sirieix P, Caldas C and Fitzgerald RC: Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev. 20:210–217. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, Yuan JM, Zheng W, Dawsey SM, Dong LM, et al: A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet. 42:764–767. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, Kawaguchi T, Tsunoda T, Kamatani N, Kubo M, Nakamura Y and Matsuda K: Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology. 137:1768–1775. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Adachi Y, Imsumran A, Yamamoto H, Piao W, Li H, Ii M, Arimura Y, Park MY, Kim D, et al: Targeting for insulin-like growth factor-I receptor with short hairpin RNA for human digestive/gastrointestinal cancers. J Gastroenterol. 45:159–170. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wu C, Hu Z, He Z, Jia W, Wang F, Zhou Y, Liu Z, Zhan Q, Liu Y, Yu D, et al: Genome-wide association study identifies three new susceptibility loci for esophageal squamous-cell carcinoma in Chinese populations. Nat Genet. 43:679–684. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, Li XM, Yu K, Shu XO, Yuan JM, et al: Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: A meta-analysis of genome-wide association studies. Hum Mol Genet. 21:2132–2141. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Moura MA, Bergmann A, Aguiar SS and Thuler LC: The magnitude of the association between smoking and the risk of developing cancer in Brazil: A multicenter study. BMJ Open. 4:e0037362014. View Article : Google Scholar : PubMed/NCBI | |
|
Postlethwait RW: Carcinoma of the thoracic esophagus. Surg Clin North Am. 63:933–940. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, Elie H and Vernhes JC: Autopsy findings in 111 cases of esophageal cancer. Cancer. 48:329–335. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Quint LE, Hepburn LM, Francis IR, Whyte RI and Orringer MB: Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 76:1120–1125. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Mao WM, Zheng WH and Ling ZQ: Epidemiologic risk factors for esophageal cancer development. Asian Pac J Cancer Prev. 12:2461–2466. 2011.PubMed/NCBI | |
|
Lambert R: Endoscopy in screening for digestive cancer. World J Gastrointest Endosc. 4:518–525. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Dawsey SM, Wang GQ, Weinstein WM, Lewin KJ, Liu FS, Wiggett S, Nieberg RK, Li JY and Taylor PR: Squamous dysplasia and early esophageal cancer in the Linxian region of China: Distinctive endoscopic lesions. Gastroenterology. 105:1333–1340. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Roth MJ, Liu SF, Dawsey SM, Zhou B, Copeland C, Wang GQ, Solomon D, Baker SG, Giffen CA and Taylor PR: Cytologic detection of esophageal squamous cell carcinoma and precursor lesions using balloon and sponge samplers in asymptomatic adults in Linxian, China. Cancer. 80:2047–2059. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Shen O, Liu SF, Dawsey SM, Cao J, Zhou B, Wang DY, Cao SG, Zhao HZ, Li GY, Taylor PR, et al: Cytologic screening for esophageal cancer: Results from 12,877 subjects from a high-risk population in China. Int J Cancer. 54:185–188. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Shu YJ: Cytopathology of the esophagus. An overview of esophageal cytopathology in China. Acta Cytol. 27:7–16. 1983.PubMed/NCBI | |
|
Pan QJ, Roth MJ, Guo HQ, Kochman ML, Wang GQ, Henry M, Wei WQ, Giffen CA, Lu N, Abnet CC, et al: Cytologic detection of esophageal squamous cell carcinoma and its precursor lesions using balloon samplers and liquid-based cytology in asymptomatic adults in Llinxian, China. Acta Cytol. 52:14–23. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Qin DX, Wang GQ, Yuan FL, Tang MZ, Li MS and Zhang ZL: Screening for upper digestive tract cancer with an occult blood bead detector. Investigation of a normal north China population. Cancer. 62:1030–1034. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Qin DX, Wang GQ, Zuo JH, Zhang XH, Yuan FL, Li MS, Wu CR and Ju CL: Screening of esophageal and gastric cancer by occult blood bead detector. Cancer. 71:216–218. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Dawsey SM, Lewin KJ, Liu FS, Wang GQ and Shen Q: Esophageal morphology from Linxian, China. Squamous histologic findings in 754 patients. Cancer. 73:2027–2037. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, Lewin KJ, Roth MJ, Tio TL and Taylor PR: Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer. 83:220–231. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, Sugiura H, Goda K, Kaise M, et al: Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: A multicenter randomized controlled trial. J Clin Oncol. 28:1566–1572. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wei WQ, Chen ZF, He YT, Feng H, Hou J, Lin DM, Li XQ, Guo CL, Li SS, Wang GQ, et al: Long-Term Follow-up of a community assignment, One-time endoscopic screening study of esophageal cancer in China. J Clin Oncol. 33:1951–1957. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Feng JF, Huang Y, Lu WS and Chen QX: Preoperative platelet count in esophageal squamous cell carcinoma: Is it a prognostic factor? Langenbeck's Arch Surg. 398:1115–1122. 2013. View Article : Google Scholar | |
|
Almhanna K, Meredith KL, Hoffe SE, Shridhar R and Coppola D: Targeting the human epidermal growth factor receptor 2 in esophageal cancer. Cancer Control. 20:111–116. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ying J, Zhang M, Qiu X and Lu Y: The potential of herb medicines in the treatment of esophageal cancer. Biomed Pharmacotherapy. 103:381–390. 2018. View Article : Google Scholar | |
|
Krasna MJ: Stage-specific therapy for cancer of the oesophagus: A new ‘cancer of the elderly’. Drugs Aging. 26:185–194. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Hagen JA, DeMeester SR, Peters JH, Chandrasoma P and DeMeester TR: Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg. 234:520–531. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Pennathur A and Luketich JD: Resection for esophageal cancer: Strategies for optimal management. Ann Thoracic Surg. 85 (Suppl):S751–S756. 2008. View Article : Google Scholar | |
|
Pennathur A, Zhang J, Chen H and Luketich JD: The ‘best operation’ for esophageal cancer? Ann Thorac Surg. 89 (Suppl):S2163–S2167. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Nishihira T, Hirayama K and Mori S: A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg. 175:47–51. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJ and Stukel TA: Volume and process of care in high-risk cancer surgery. Cancer. 106:2476–2481. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Thar Min AK, Shibata M, Momma T, Saze Z, et al: Immunotherapy for esophageal squamous cell carcinoma: A review. Fukushima J Med Sci. 64:46–53. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Vrana D, Matzenauer M, Neoral Č, Aujeský R, Vrba R, Melichar B, Rušarová N, Bartoušková M and Jankowski J: From Tumor immunology to immunotherapy in gastric and esophageal cancer. Int J Mol Sci. 20:E132018. View Article : Google Scholar : PubMed/NCBI | |
|
Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR and Belani CP: Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Ann Thorac Surg. 85:1930–1937. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, Kiel K, Willett C, Sugarbaker D and Mayer R: Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 26:1086–1092. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N and Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:462–467. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, Takiyama W, Watanabe H, Isono K, Aoyama N, et al: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol. 21:4592–4596. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Ando N, Ozawa S, Kitagawa Y, Takeuchi H and Kitajima M: Salvage surgery for the T4 esophageal cancer following downstaging by neoadjuvant chemoradiotherapy. Nihon Geka Gakkai Zasshi. 98:767–772. 1997.(In Japanese). PubMed/NCBI | |
|
Armanios M, Xu R, Forastiere AA, Haller DG, Kugler JW and Benson AB III; Eastern Cooperative Oncology Group, : Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: Phase II trial (E8296) of the Eastern Cooperative Oncology Group. J Clin Oncol. 22:4495–4499. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Kleinberg L and Forastiere AA: Chemoradiation in the management of esophageal cancer. J Clin Oncol. 25:4110–4117. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Stahl M, Wilke H, Stuschke M, Walz MK, Fink U, Molls M, Siewert JR, Schroeder M, Makoski HB, Schmidt U, et al: Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer. J Cancer Res Clin Oncol. 131:67–72. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Polednak AP: Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 105:98–100. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Homs MY, Steyerberg EW, Eijkenboom WM and Siersema PD: Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy. 5:41–48. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Shah MA, Ramanathan RK, Ilson DH, Levnor A, D'Adamo D, O'Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, et al: Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma. J Clin Oncol. 24:5201–5206. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Batouli A, Jahanshahi P, Gross CP, Makarov DV and Yu JB: The global cancer divide: Relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries. J Epidemiol Glob Health. 4:115–124. 2014. View Article : Google Scholar : PubMed/NCBI |
